Recombinant Salmon Calcitonin (Biodel)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Salmon Calcitonin (Biodel)
Drug Alias NameVIAcal
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCalcitonin receptor agonists
TargetsCalcitonin receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbireo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbireo Pharma Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A